ADTX News and Press, ADiTx Therapeutics Inc. From 08/11/21

AditxtScore™ for COVID-19 now offered in Great Lakes Medical Laboratory locations, allowing Michiganders and their physicians to monitor and evaluate their COVID-19 immune response Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the...

Psoriasis First-in-Human (Phase I/IIa) program is slated for 2022 Type 1 Diabetes and Skin Allografting are planned to enter clinical trials in 2022 Pre-clinical investigational work has started in Multiple Sclerosis Aditxt, Inc. (the “Company” or ...

EyeGate Pharmaceuticals EYEG +127% names Brian Strem CEO, proposes $7M Bayon dealObsEva SA OBSV +28%, Organon ink ebopiprant licensing deal for preterm laborOrbsat Corp. (OSAT) +27%.MOGU Inc. (MOGU) +21%  announces entry into Definitive Agreements to increase ownershi...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Greetings, trader! Join me as we dive into the biggest pre-market stock movers for Tuesday. Source: f11photo/Shutterstock.com But before that, check out our overview of important stock stories from Monday. The extra...

AditxtScore™ for COVID-19 Now Includes Virus-Specific Infection Blocking Antibodies that Assess the Strength of an Individual’s Immune Response to SARS-CoV-2 Aditxt, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to im...

AditxtScore TM Center to Become Global Headquarters for Aditxt as a Biotech Innovator Focused on Immune Health Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtSc...

Aditx Therapeutics (ADTX) announces that Lauren Chung will join the company's board of directors as an independent director.Chung has over 20 years of healthcare investment management, investment banking, and advisory experience, and is currently a venture partner at Yozma...

As an independent director, Dr. Chung brings deep expertise in healthcare investment and corporate development Aditx Therapeutics, Inc. (“Aditxt”) (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announ...

Aditx Therapeutics (ADTX) to join the Russell Microcap Index, effective after the US market opens on June 28, 2021.ADTX +4.7% premarket to $3.08Source: Press Release For further details see: Aditxt to join Russell Microcap index

Aditxt Set to Join Russell Microcap® Index PR Newswire MOUNTAIN VIEW, Calif. , June 15, 2021 /PRNewswire/ -- Aditx Therapeutics, Inc. ("Aditxt") (NASDAQ: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today...